摘要
The optimal treatment for respiratory distress syndrome （RDS） in extremely low birth weight newbom infants now consists of surfactant therapy, ventilator support and aggressive nutritional support. Introduction of surfactant therapy has significantly reduced both the mortality and morbidity in premature infants. However, despite all the preventive efforts the prematurity rate has increased in the United States. As a result of this trend the majority of the infants requiring mechanical ventilation in the current neonatal intensive care units are less than 1000 g.
The optimal treatment for respiratory distress syndrome （RDS） in extremely low birth weight newbom infants now consists of surfactant therapy, ventilator support and aggressive nutritional support. Introduction of surfactant therapy has significantly reduced both the mortality and morbidity in premature infants. However, despite all the preventive efforts the prematurity rate has increased in the United States. As a result of this trend the majority of the infants requiring mechanical ventilation in the current neonatal intensive care units are less than 1000 g.
